(in millions $) | 1 May 2023 | 31 Jan 2023 | 30 Oct 2022 | 30 Jul 2022 |
---|---|---|---|---|
Current assets | ||||
Cash | ||||
Short term investments | ||||
Net receivables | ||||
Inventory | ||||
Total current assets | ||||
Long term investments | ||||
Property, plant & equipment | $6929 | $7371 | $7448 | |
Goodwill & intangible assets | ||||
Total noncurrent assets | ||||
Total investments | ||||
Total assets | $540291 | $531358 | $700358 | $727365 |
Current liabilities | ||||
Accounts payable | $2682 | $11442 | $12189 | $11955 |
Deferred revenue | ||||
Short long term debt | ||||
Total current liabilities | $128564 | $11442 | $15260 | $15132 |
Long term debt | $151261 | $157235 | $162605 | $158010 |
Total noncurrent liabilities | ||||
Total debt | ||||
Total liabilities | $486225 | $486229 | $657091 | $681523 |
Shareholders' equity | ||||
Retained earnings | $36059 | $23632 | $25025 | $29059 |
Other shareholder equity | -$20607 | -$16850 | -$16265 | -$17544 |
Total shareholder equity |
(in millions $) | 31 Jan 2023 | 31 Jan 2022 | 30 Jan 2021 | 30 Jan 2020 |
---|---|---|---|---|
Current assets | ||||
Cash | $148376.9 | $102541.2 | ||
Short term investments | ||||
Net receivables | $38334.67 | $35879.71 | ||
Inventory | ||||
Total current assets | ||||
Long term investments | ||||
Property, plant & equipment | $6929 | $7305 | $7376 | $7832 |
Goodwill & intangible assets | ||||
Total noncurrent assets | ||||
Total investments | ||||
Total assets | $531358 | $755833 | $859489.8 | $792412.4 |
Current liabilities | ||||
Accounts payable | $11442 | $17029 | $23095.09 | $25849.94 |
Deferred revenue | ||||
Short long term debt | ||||
Total current liabilities | $11442 | $46788 | $54247 | $58571 |
Long term debt | $157235 | $140413 | $171815.4 | $152993 |
Total noncurrent liabilities | ||||
Total debt | ||||
Total liabilities | $486229 | $711879 | $813688.9 | $748414.3 |
Shareholders' equity | ||||
Retained earnings | $23632 | $31064 | $35020.75 | $30833.12 |
Other shareholder equity | -$16850 | -$21339 | -$24409.72 | -$20329.94 |
Total shareholder equity |
(in millions $) | 1 May 2023 | 31 Jan 2023 | 30 Oct 2022 | 30 Jul 2022 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $3804 | $3645 | ||
Cost of revenue | ||||
Gross Profit | ||||
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | ||||
Total operating expenses | ||||
Operating income | ||||
Income from continuing operations | ||||
EBIT | ||||
Income tax expense | $3698 | $419 | ||
Interest expense | ||||
Net income | ||||
Net income | -$4034 | -$1593 | ||
Income (for common shares) |
(in millions $) | 31 Jan 2023 | 31 Jan 2022 | 30 Jan 2021 | 30 Jan 2020 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $22696 | $23880.1 | $22630.15 | |
Cost of revenue | ||||
Gross Profit | ||||
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | ||||
Total operating expenses | ||||
Operating income | ||||
Income from continuing operations | ||||
EBIT | ||||
Income tax expense | $1026 | $854.35 | $1303.42 | |
Interest expense | $8501.87 | $13252.59 | ||
Net income | ||||
Net income | -$1650 | $2846.76 | $3441.22 | |
Income (for common shares) |
(in millions $) | 31 Jan 2023 | 30 Oct 2022 | 30 Jul 2022 | 1 May 2022 |
---|---|---|---|---|
Net income | ||||
Operating activities | ||||
Depreciation | ||||
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | ||||
Investing activities | ||||
Capital expenditures | ||||
Investments | ||||
Total cash flows from investing | $55542 | $4668 | $3683 | $14495 |
Financing activities | ||||
Dividends paid | -$280 | -$280 | -$280 | |
Sale and purchase of stock | ||||
Net borrowings | ||||
Total cash flows from financing | -$163883 | -$24839 | -$5794 | -$6559 |
Effect of exchange rate | -$1819 | -$813 | $2 | -$159 |
Change in cash and equivalents | -$96340 | -$15627 | -$5346 | $3132 |
(in millions $) | 31 Jan 2023 | 31 Jan 2022 | 30 Jan 2021 | 30 Jan 2020 |
---|---|---|---|---|
Net income | $2843.56 | $3447.26 | ||
Operating activities | ||||
Depreciation | ||||
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | -$6947.83 | -$18543.76 | ||
Investing activities | ||||
Capital expenditures | ||||
Investments | ||||
Total cash flows from investing | $55542 | -$10082 | $17784.49 | -$1334.62 |
Financing activities | ||||
Dividends paid | -$280 | -$257 | -$763.69 | -$700.52 |
Sale and purchase of stock | ||||
Net borrowings | ||||
Total cash flows from financing | -$163883 | -$47 | $31720.68 | $22333.23 |
Effect of exchange rate | -$1819 | -$1103 | -$2844.62 | -$610.95 |
Change in cash and equivalents | -$96340 | $25706 | $39712.72 | $1843.91 |
BNP Slumps as Lending Headwinds Linger, Equities Miss
Bloomberg · via Yahoo Finance
31 Oct 2024
|
AXA IM Trims French Bank Stocks With Bond Risk a Lasting Trend
Bloomberg · via Yahoo News
19 Jun 2024
|
BNP Paribas (BNPQY) in Talks to Form Asset Management JV With Axa
Zacks · via Yahoo Finance
19 Jun 2024
|
AXA SA's Dividend Analysis
GuruFocus.com via Yahoo Finance
26 Apr 2024
|
AXAHY vs. ZURVY: Which Stock Is the Better Value Option?
Zacks via Yahoo Finance
13 Mar 2024
|
Is Axa (AXAHY) Outperforming Other Finance Stocks This Year?
Zacks via Yahoo Finance
11 Mar 2024
|
AXAHY vs. ZURVY: Which Stock Should Value Investors Buy Now?
Zacks via Yahoo Finance
26 Feb 2024
|
AXAHY or ZURVY: Which Is the Better Value Stock Right Now?
Zacks via Yahoo Finance
28 Jan 2024
|
AXAHY vs. ZURVY: Which Stock Is the Better Value Option?
Zacks via Yahoo Finance
11 Jan 2024
|
Axa Sa (AXAHY) Moves to Buy: Rationale Behind the Upgrade
Zacks · via Yahoo Finance
21 Oct 2023
|
Market cap | $129.21B |
---|---|
Enterprise value | N/A |
Shares outstanding | 3.86B |
Revenue | N/A |
---|---|
EBITDA | N/A |
EBIT | N/A |
Net Income | N/A |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
P/E ratio | N/A |
---|---|
EV/Sales | N/A |
EV/EBITDA | N/A |
EV/EBIT | N/A |
P/S ratio | N/A |
P/B ratio | N/A |
Book/Share | N/A |
Cash/Share | N/A |
EPS | N/A |
---|---|
ROA | N/A |
ROE | N/A |
Debt/Equity | N/A |
---|---|
Net debt/EBITDA | N/A |
Current ratio | N/A |
Quick ratio | N/A |